Menstrual cycle length and adverse pregnancy outcomes among women in Project Viva.

ABSTRACT:

Background

Retrospective studies suggest that menstrual cycle length may be a risk marker of adverse pregnancy outcomes, but this evidence is susceptible to recall bias.

Objective

To evaluate the prospective association between menstrual cycle length and the risk of adverse pregnancy outcomes.

Methods

Secondary analysis of 2046 women enrolled in Project Viva at ~10 weeks of gestation and followed through delivery. The exposure was menstrual cycle length. The outcomes included gestational glucose tolerance (gestational diabetes/impaired glucose tolerance [GDM/IGT] and isolated hyperglycaemia), hypertensive disorders of pregnancy (gestational hypertension/preeclampsia), gestational weight gain, birthweight-for-gestational age z-scores (BWZ) categorised in tertiles, pret

SUBMITTER: Soria-Contreras DC 

PROVIDER: S-EPMC9050743 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature